HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urolithiasis in the COVID Era: An Opportunity to Reassess Management Strategies.

Abstract
Delayed evaluation and/or treatment for urolithiasis during the COVID-19 pandemic provide a unique opportunity to organically reassess many well-established stone management strategies. Nonopioid analgesia for renal colic and spontaneous passage trials appear to be two avenues worthy of investigation.
AuthorsRyan L Steinberg, Brett A Johnson, Jodi Antonelli, Margaret S Pearle
JournalEuropean urology (Eur Urol) Vol. 78 Issue 6 Pg. 777-778 (12 2020) ISSN: 1873-7560 [Electronic] Switzerland
PMID32747201 (Publication Type: Editorial)
CopyrightCopyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Analgesics, Opioid
Topics
  • Analgesics, Opioid (therapeutic use)
  • COVID-19 (epidemiology)
  • Humans
  • Medical Overuse
  • Referral and Consultation (statistics & numerical data)
  • Renal Colic (drug therapy, etiology)
  • SARS-CoV-2
  • Self Care
  • Texas (epidemiology)
  • Urolithiasis (complications, therapy)
  • Urology (methods, statistics & numerical data)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: